Schematic representation of option 1 by which all patients with newly diagnosed disease receive a “trial” of STI571.

Those who do not respond (as defined in the text) may proceed to undergo allo-SCT if they are young enough and have a suitable stem cell donor. NMSCT, nonmyeloablative stem cell transplantation.